These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 319922)

  • 41. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.
    MacKay JH; Arcuri KE; Goldberg AI; Snapinn SM; Sweet CS
    Arch Intern Med; 1996 Feb; 156(3):278-85. PubMed ID: 8572837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oxprenolol vs propranolol: a randomized, double-blind, multiclinic trial in hypertensive patients taking hydrochlorothiazide. Veterans Administration Cooperative Study Group.
    Hypertension; 1981; 3(2):250-6. PubMed ID: 7011964
    [TBL] [Abstract][Full Text] [Related]  

  • 43. THE EFFECTS OF BETHANIDINE ON THE PERIPHERAL CIRCULATION IN MAN.
    FEWINGS JD; HODGE RL; SCROOP GC; WHELAN RF
    Br J Pharmacol Chemother; 1964 Aug; 23(1):115-22. PubMed ID: 14208188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiclinic evaluation of the antihypertensive effect of a methyldopa, hydrochlorothiazine, and amiloride combination.
    Moncloa F; Hwang IK; Muccilli AC
    Clin Ther; 1980; 3(3):168-75. PubMed ID: 7006811
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bethanidine elimination from plasma.
    Corder CN
    J Clin Pharmacol; 1979; 19(8-9 Pt 1):428-34. PubMed ID: 489762
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiarrhythmic and electrophysiologic actions of bethanidine sulfate in primary ventricular fibrillation or life-threatening ventricular tachycardia.
    Benditt DG; Benson DW; Dunnigan A; Kriett JM; Pritzker MR; Bacaner MB
    Am J Cardiol; 1984 May; 53(9):1268-74. PubMed ID: 6711426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antagonism of bethanidine by mazindol.
    Boakes AJ
    Br J Clin Pharmacol; 1977 Aug; 4(4):486-7. PubMed ID: 901743
    [No Abstract]   [Full Text] [Related]  

  • 48. [Guanethidine-hydrochlorothiazide combination in the treatment of arterial hypertension].
    Trompetto G
    Clin Ter; 1974 Dec; 71(6):563-71. PubMed ID: 4448053
    [No Abstract]   [Full Text] [Related]  

  • 49. [Comparative study of the antihypertensive effect of guanfacine and guanethidine].
    Kállay K; Szám I; Káldi N
    Orv Hetil; 1981 Jul; 122(29):1777-83. PubMed ID: 7027137
    [No Abstract]   [Full Text] [Related]  

  • 50. Diuretics versus calcium-channel blockers in systemic hypertension: a preliminary multicenter experience with hydrochlorothiazide and sustained-release diltiazem.
    Frishman WH; Kirkendall W; Lunn J; McCarron D; Moser M; Schnaper H; Smith LK; Sowers J; Swartz S; Zawada E
    Am J Cardiol; 1985 Dec; 56(16):92H-96H. PubMed ID: 3907323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dose-effect and concentration-effect relationships of pinacidil and hydrochlorothiazide in hypertension.
    Goldberg MR; Rockhold FW; Offen WW; Dornseif BE
    Clin Pharmacol Ther; 1989 Aug; 46(2):208-18. PubMed ID: 2758730
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Experiences with the treatment of hypertension with a combination of guanethidine and hydrochlorothiazide (Esimil)].
    Michot F
    Praxis; 1967 Nov; 56(45):1531-4. PubMed ID: 5632024
    [No Abstract]   [Full Text] [Related]  

  • 53. [A controlled blind study of 4 antihypertensive agents (methyldopa and 3 sympatholytic agents)].
    Vejlsgaard V; Christensen M; Clausen E
    Ugeskr Laeger; 1967 May; 129(19):635-8. PubMed ID: 4877293
    [No Abstract]   [Full Text] [Related]  

  • 54. Blood volume and exchangeable sodium during treatment of hypertension with guanethidine and hydrochlorothiazide.
    Ronnov-Jessen V; Hansen J
    Acta Med Scand; 1969 Oct; 186(4):255-63. PubMed ID: 5378104
    [No Abstract]   [Full Text] [Related]  

  • 55. Angina in hypertensive patients. With particular reference to the negative chronotropic effects of sympatholytic therapy.
    Talbot S
    Cardiology; 1976; 61(4):254-66. PubMed ID: 13931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antihypertensive therapy with nitrendipine: comparison with hydrochlorothiazide and propranolol.
    Massie BM
    J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S55-8. PubMed ID: 2468874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical study of hypotensive agent: Esimil].
    Warembourg H; Stalnikiewicz G
    Lille Med; 1970; 15():Suppl 5:993-8. PubMed ID: 4921128
    [No Abstract]   [Full Text] [Related]  

  • 58. Antiarrhythmic, antifibrillatory, and hemodynamic actions of bethanidine sulfate: an orally effective analog of bretylium for suppression of ventricular tachyarrhythmias.
    Bacaner MB; Benditt DG
    Am J Cardiol; 1982 Oct; 50(4):728-34. PubMed ID: 6812406
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of guanadrel and guanethidine.
    Hansson L; Pascual A; Julius S
    Clin Pharmacol Ther; 1973; 14(2):204-8. PubMed ID: 4571980
    [No Abstract]   [Full Text] [Related]  

  • 60. Evaluation of guanabenz added to hydrochlorothiazide therapy in hypertension.
    Walker BR; Deitch MW; Gold JA; Levey BA
    J Int Med Res; 1982; 10(3):131-9. PubMed ID: 7047256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.